Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TransMedics Group, Inc.TMDX · Entity 4261 | Chief Financial Officer | June 03, 2024 | June 05, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TransMedics Group, Inc.
Report date June 03, 2024 · Filed June 05, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 21,299 |
Ending reported balance
After 2024-06-03 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-06-03 · Exercise / conversion · Acquired 2,060 · Balance 23,359 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023. Row 2 · 2024-06-03 · Sale · Disposed 2,060 · Balance 21,299 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.46 · Expires 2031-02-24 | Direct | 15,417 |
Reported balance
After 2024-06-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-06-03 · Exercise / conversion · Disposed 2,060 · Balance 15,417 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023. F2: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023.
F2: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 04, 2021 Filed Jan 5, 2021 23:04 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 1,184 | $20.00 | $23,680.00 |
DisclosureSEC source: 0000899243-21-000439 · doc4.xml · nonDerivative · entry 2 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,371 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 23:04 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 8,816 | $20.00 | $176,320.00 |
DisclosureSEC source: 0000899243-21-000439 · doc4.xml · nonDerivative · entry 1 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,755 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 27, 2020 Filed Apr 29, 2020 20:22 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 9,900 | $18.00 | $178,200.00 |
DisclosureSEC source: 0000899243-20-011556 · doc4.xml · nonDerivative · entry 1 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,571 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 22, 2020 Filed Apr 24, 2020 21:54 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 100 | $18.00 | $1,800.00 |
DisclosureSEC source: 0000899243-20-011314 · doc4.xml · nonDerivative · entry 1 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,471 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 27, 2020 Filed Mar 6, 2020 23:15 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $16.14 | $0.00 |
DisclosureSEC source: 0000899243-20-007520 · doc4.xml · derivative · entry 1 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-02-27 F1 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020. Read SEC document |
| May 06, 2019 Filed May 6, 2019 22:46 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | OtherStock Option (Right to Buy) · Derivative | 40,728 | Not disclosed Strike: $2.21 | Not disclosed |
DisclosureSEC source: 0000899243-19-012299 · doc4.xml · derivative · entry 6 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,728 Underlying: Common Stock · 40,728 shares Expires 2027-06-22 F3 · derivative.exercise_price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · kind: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · shares: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F4 · derivative.exercise_date: The options vests at a rate of 2.0833% of the total number shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, June 22, 2017. Read SEC document |
| May 06, 2019 Filed May 6, 2019 22:46 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | OtherStock Option (Right to Buy) · Derivative | 142,551 | Not disclosed Strike: $0.63 | Not disclosed |
DisclosureSEC source: 0000899243-19-012299 · doc4.xml · derivative · entry 5 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,728 shares Expires 2027-06-22 F3 · derivative.exercise_price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · kind: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · shares: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F4 · derivative.exercise_date: The options vests at a rate of 2.0833% of the total number shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, June 22, 2017. Read SEC document |
| May 06, 2019 Filed May 6, 2019 22:46 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | OtherStock Option (Right to Buy) · Derivative | 57,142 | Not disclosed Strike: $0.67 | Not disclosed |
DisclosureSEC source: 0000899243-19-012299 · doc4.xml · derivative · entry 4 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,142 Underlying: Common Stock · 57,142 shares Expires 2025-04-01 F3 · derivative.exercise_price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · kind: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · shares: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F2 · derivative.exercise_date: The option vested 25% on the first anniversary of the vesting commencement date, March 23, 2015, and at a rate of 2.0833% each month thereafter until the option is fully vested on the fourth anniversary of the vesting date. Read SEC document |
| May 06, 2019 Filed May 6, 2019 22:46 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | OtherStock Option (Right to Buy) · Derivative | 200,000 | Not disclosed Strike: $0.19 | Not disclosed |
DisclosureSEC source: 0000899243-19-012299 · doc4.xml · derivative · entry 3 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 57,142 shares Expires 2025-04-01 F3 · derivative.exercise_price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · kind: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · shares: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F3 · price: The Stock Options reported herein as being disposed of are options to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price. F2 · derivative.exercise_date: The option vested 25% on the first anniversary of the vesting commencement date, March 23, 2015, and at a rate of 2.0833% each month thereafter until the option is fully vested on the fourth anniversary of the vesting date. Read SEC document |
| May 06, 2019 Filed May 6, 2019 22:46 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | OtherCommon Stock | 28,571 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-012299 · doc4.xml · nonDerivative · entry 2 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,571 F1 · kind: The Common Stock reported herein as being disposed of is common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the "Merger Agreement"), such common stock of TransMedics, Inc. was converted into shares of common stock of the Issuer on a 3.5-for-one basis. F1 · price: The Common Stock reported herein as being disposed of is common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the "Merger Agreement"), such common stock of TransMedics, Inc. was converted into shares of common stock of the Issuer on a 3.5-for-one basis. Read SEC document |
| May 06, 2019 Filed May 6, 2019 22:46 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | OtherCommon Stock | 100,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-012299 · doc4.xml · nonDerivative · entry 1 Gordon Stephen · CIK 0001774274 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The Common Stock reported herein as being disposed of is common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the "Merger Agreement"), such common stock of TransMedics, Inc. was converted into shares of common stock of the Issuer on a 3.5-for-one basis. F1 · price: The Common Stock reported herein as being disposed of is common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Agreement and Plan of Merger and Reorganization by and among the Issuer, TransMedics, Inc. and TMDX, Inc., dated April 15, 2019 (the "Merger Agreement"), such common stock of TransMedics, Inc. was converted into shares of common stock of the Issuer on a 3.5-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.